EcoVadis Platinum Level Achieved in 2026
We have renewed our EcoVadis assessment and achieved the Platinum level!
History
What is our
Raison d'être
HTL Biotechnology’s mission is to unleash the potential of hyaluronic acid and biopolymers for the benefit of those seeking to improve the health and well-being of millions of patients worldwide.
1977
Foundation of Javenech, a biotechnology research lab committed to human health
1992
Foundation of HTL Biotechnology
1992-2006
Pioneer in Hyaluronic Acid production by bacterial fermentation
2007-2016
HTL Biotechnology becomes the world leader in injectable grade Hyaluronic Acid
2017
Investments in large R&D and production projects
2019
Fermentation-based production of new biopolymers of medical interest
2021
Opening of the new GMP manufacturing facility HTL4
Opening of US and Asia offices
First strategic partnership on functionalized biopolymers
2023
New GMP chemistry facility to functionalized Biopolymers
2025
A new sterile Hyaluronic Acid production unit
HTL8, new production unit for Collagen
A leader for
45 years
The HTL Biotechnology of the future means :
- The constant creation of new and innovative products thanks to our R&D investments. Our ambition is to continue shaping the future of medicine and the biopolymer market,
- An ever-increasing number of applications for our biopolymers,
- A global expansion, from the United States to Asia, while strengthening our teams in France.
